Articles written by Kyle Dennis - Benzinga

Exelixis Data Release Upcoming; Options Activity Spiking

Why Investors Are Watching Athersys Ahead Of Stem Cell Data

Last Week's Biotech IPO Recap

Zogenix Received FDA Approval, Now What?

What Investors Are Watching For In Regulus Therapeutics' Next Data Release

Stocks That Battle Cancer Were The Best-Performing Biotechs In January

Baird Releases Comments After Vertex Earnings Call

Baird Remains Buyers Of Gilead Before Earnings Release

Two New Biotech IPOs Debut Friday, One Deal Delayed

What You Need To Know About The Spark Therapeutics IPO

4 More Biotech IPOs Going Public This Week

Another Reason MannKind Could Be Up (In 1 Tweet)

3 Biotech IPOs Debuting This Week

What Investors Are Watching Ahead of Zogenix's FDA Approval Decision

Why Nevro Is Trading 25% Higher

Catalysts To Watch For In RBC Capital's 2015 Top Small-Cap Biotechs

Deutsche Bank Loves These Small-Cap Biotech Stocks

Why Minerva Neurosciences Is Trading Higher

4 More Biotech Secondaries Traders Are Watching

5 Biotech Secondaries Traders Are Watching